Evidence map›Paper›PMID 23757263›Full record

ReviewCurrent opinion in neurology2013

Primary and secondary dystonic syndromes: an update.

Gavin Charlesworth, Kailash P Bhatia

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in neurology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. [Clinical manifestations and genetic diagnosis of paroxysmal kinesigenic dyskinesia].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2017
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Gavin CharlesworthDepartment of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
Kailash P Bhatia
University College London · GB

Funding

Medical Research Council MC_G1000735Wellcome Trust 089698
6 · The paper itself

Abstract

purpose of reviewThe dystonias are a common but complex group of disorders that show considerable variation in cause and clinical presentation. The purpose of this review is to highlight the most important discoveries and insights from across the field over the period of the past 18 months. RECENT

findingsFive new genes for primary dystonia (PRRT2, CIZ1, ANO3, TUBB4A and GNAL) have made their appearance in the literature. New subtypes of neuronal brain iron accumulation have been delineated and linked to mutations in C19orf12 and WDR45, while a new treatable form of dystonia with brain manganese deposition related to mutations in SLC30A10 has been described. At the same time, the phenotypes of other forms of dystonic syndromes have been expanded or linked together. Finally, there has been increasing recognition of both the extramotor phenotype in dystonia and the part played by the cerebellum in its pathophysiology. SUMMARY: Recently, there has been unprecedented change in the scientific landscape with respect to the cause of various dystonic syndromes that is likely to make a direct impact on clinical practice in the near future. Understanding the genetic cause of these syndromes and the often wide phenotypic variation in their presentations will improve diagnosis and treatment. With time, these discoveries may also lead to much-needed progress in elucidating the underlying pathophysiology of dystonia.

Indexed as

Genetic Predisposition to DiseaseAnoctaminsCerebellumChloride ChannelsDystoniaGTP-Binding Protein alpha SubunitsHumansMembrane ProteinsMutationNerve Tissue ProteinsNuclear ProteinsPhenotypeTubulinANO3 protein, humanAnoctaminsChloride ChannelsCiz1 protein, humanGTP-Binding Protein alpha SubunitsMembrane ProteinsNerve Tissue ProteinsNuclear Proteinsolfactory G protein subunit alpha olfPRRT2 protein, humanTUBB4A protein, humanTubulin

Identifiers

PMID23757263
PMCPMC4196839
OpenAlexW2008550294

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.